Author Archives for Adeline Chauvigné

InFlectis BioScience licenses rights to a potential new class of therapies for demyelinating diseases from the University of Chicago

5 July 2025

InFlectis BioScience has been granted exclusive patent rights from the University of Chicago to use a family of small molecules for the treatment... View Article

Jessica Walker has been elected Board Member of the Council of European Bioregions!

5 July 2025

Atlanpole Biotherapie’s European project manager Jessica Walker has been elected Board Member of the Council of European Bioregions! This European... View Article

Oncology: infrared light could help surgeons see more clearly the tumors during operations

5 July 2025

The University Medical Center Groningen and Kaer Labs announce entering into a research collaboration to evaluate NIR-II fluorescence for biological... View Article

New partner | 2 do it

5 July 2025

Engaged in relational performance in business, Lucie Léger strongly believes that we can transform businesses and employees ! Reinvent relational... View Article

New partner | SinnRJ

5 July 2025

SinnRJ’s core activity is to support innovative structures (SMEs, large groups, academic laboratories) in obtaining regional, French and especially European... View Article

New partner | Strategiqual

5 July 2025

Strategiqual is a leading consultancy organization highly skilled for drugs, medical devices and in vitro medical devicesprojects. Strategiqual provides companies... View Article

New partner | Alison Munro

5 July 2025

25+ years dedicated to Health innovation. Founded Alison Munro Corporate Language (AMCL) in 2005. Has coached 350+ startups & top-notch... View Article

Valneva completes recruitment for Phase 3 Lot-to-Lot Consistency Trial of its Chikungunya Vaccine Candidate

5 July 2025

Valneva,  a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet... View Article

Valneva completes Phase 3 trial recruitment for its inactivated COVID-19 vaccine candidate

5 July 2025

Valneva , a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant... View Article

New member | Learn & Go

5 July 2025

Kaligo digital learning book, initially dedicated to early childhood, is based on the stages of the active learning approach: production... View Article